OTTAWA - Health Canada is warning consumers not to use the product M1T (methyl-1-testosterone) Andro Technologies, or any other supplements containing the synthetic steroid methyl-1-testosterone, due to such potentially serious health risks as liver disorders and hardening of the arteries.

M1T (methyl-1-testosterone) Andro Technologies, promoted for use as a legal steroid and body building supplement, has not been authorized for sale in Canada. To date, Health Canada has received one serious adverse reaction report of liver toxicity involving M1T (methyl-1-testosterone) Andro Technologies as a suspected agent.

Methyl-1-testosterone, a derivative of the steroid testosterone, is a controlled substance in Canada. There are currently no authorized methyl-1-testosterone products on the Canadian market. When used improperly, methyl-1-testosterone can cause serious adverse reactions, including reduced fertility, hardening of the arteries, liver damage and enlargement or tenderness of male breasts or nipples.

Canadians using M1T (methyl-1-testosterone) Andro Technologies or any other supplements containing this steroid are advised to stop taking these products immediately and consult with a health care professional if they have health concerns.

Health Canada has notified the Canada Border Services Agency to detain any shipment of M1T (methyl-1-testosterone) Andro Technologies or any other products containing methyl-1-testosterone at the border.

Canadians are advised to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find M1T (methyl-1-testosterone) Andro Technologies or any other products containing methyl-1-testosterone on the Canadian market.

Consumers and health care professionals are encouraged to report any adverse reaction suspected as being associated with methyl-1-testosterone use by contacting the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods: Toll-free telephone at 1-866-234-2345 or by toll-free fax at 1-866-678-6789.

CADRMP
Marketed Health Products Directorate
Health Protection Building, Tunney’s Pasture, AL 0701C

Email: cadrmp@hc-sc.gc.ca

-30-

Media Enquiries:
Christopher Williams
Health Canada
(613) 948-4250

Public Enquiries:
(613) 957-2991
1-866 225-0709


	Last Updated: 2006-02-06		Important Notices